Open-label phase II study of everolimus plus endocrine therapy in post-menopausal women with ER+, HER2- metastatic breast cancer (Chloe trial)

Shien, T. ; Shimomura, A. ; Uemura, Y. ; Kato, H. ; Kitada, M. ; Kikawa, Y. ; Shiba, E. ; Yoshida, T. ; Morimoto, T. ; Toyama, T. ; Aihara, T. ; Mukai, H.

Annals of oncology, 2017-09, Vol.28, p.v104-v104 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível